Publications by authors named "Yaseen Mallawi"

Article Synopsis
  • ARVC/D is a hereditary heart condition that leads to serious arrhythmias, primarily affecting the right ventricle, and can be treated with an implantable cardioverter defibrillator (ICD), which is effective but may deliver inappropriate treatments.
  • A study reviewed 22 ARVC/D patients who received ICDs at a hospital in Riyadh, finding that half experienced appropriate ICD therapies over an average follow-up of nearly 9.5 years, while a smaller percentage had inappropriate treatments.
  • The findings highlight that while ICDs are crucial for managing the life-threatening risks of ARVC/D, vigilance regarding inappropriate shocks is necessary.
View Article and Find Full Text PDF

Background: Subcutaneous implantable cardioverter defibrillator (S-ICD) system has been proven to be an effective therapy for prevention of sudden cardiac death (SCD) in selected patients. Although the Shockless IMPLant Evaluation (SIMPLE) trial has shown that defibrillation threshold (DFT) testing is not necessary for transvenous ICD (TV-ICD) systems, it is still recommended for S-ICD systems. We aimed to study the efficacy and safety of S-ICD implantation without DFT in our Heart Center with the comparison of S-ICD patients' outcome to those with a single chamber TV-ICD without DFT in the same period.

View Article and Find Full Text PDF

Background: Congenital long QT syndrome (LQTS) is an inherited, potentially fatal arrhythmogenic disorder. At least 16 genes have been implicated in LQTS; the yield of genetic analysis of 3 genes (KCNQ1, KCNH2, and SCN5A) is about 70%, with KCNQ1 mutations accounting for ∼50% of positive cases. LQTS is mostly inherited in an autosomal dominant pattern.

View Article and Find Full Text PDF

Background: Permanent pacemaker (PPM) implantation after cardiac surgery is required in 0.4-6% of patients depending on cardiac surgery type. PPM implantation in the early postoperative period may reduce morbidity and postoperative hospital stay.

View Article and Find Full Text PDF

Background And Objectives: Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is a rare genetic disorder that primarily involves the right ventricle (RV). It is characterized by progressive replacement of RV myocardium by fibrofatty tissues. It commonly presents with ventricular tachycardia (VT) of RV origin and may result in RV failure.

View Article and Find Full Text PDF